MRNA level in-situ hybridization detection kit for beta-catenin of liver cancer prophase as well as detection method and application of mRNA level in-situ hybridization detection kit

A detection kit and in situ hybridization technology, applied in the related detection technology field of mRNA expression changes, can solve problems such as non-decreasing mortality, drug resistance of tumor cells, failure of anti-cancer battle, etc., and achieve strong specificity and high sensitivity , the effect of convenient operation

Inactive Publication Date: 2012-07-18
NATUREGEN BIOTECH SHANGHAI
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In 2005, eight institutions including the US Institutes of Health, the Cancer Institute, and the Centers for Disease Control and Prevention made an annual report, reviewing the anti-cancer war launched in 1972. The report believed that human beings had failed in the anti-cancer war, and the conclusion was that cancer died The rate did not decrease, and it listed several factors that caused the failure of the anti-cancer war: 1. Tumor cell heterogeneity (polymorphism); 2. Tumor cell drug resistance; 3. Incomplete design of anti-cancer drugs (animals) unscientific model design), etc.
[0014] In view of the current clinical diagnosis of cancer (imaging medicine and biochemical indicators are all diagnosed after tumor formation) is a late diagnosis, treatment is also a late treatment, leading to a treatment model that does not reduce mortality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MRNA level in-situ hybridization detection kit for beta-catenin of liver cancer prophase as well as detection method and application of mRNA level in-situ hybridization detection kit
  • MRNA level in-situ hybridization detection kit for beta-catenin of liver cancer prophase as well as detection method and application of mRNA level in-situ hybridization detection kit
  • MRNA level in-situ hybridization detection kit for beta-catenin of liver cancer prophase as well as detection method and application of mRNA level in-situ hybridization detection kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Prepare the in situ hybridization kit of the present embodiment according to conventional methods, the kit includes hybridization probes, markers, and instructions designed with the beta-catenin gene as the detection target gene, wherein:

[0055] Digoxigenin was selected as the probe label in this embodiment.

[0056] Kit hybridization solution composition:

[0057] digestive juice 100μL / tube 1 tube / box colorless transparent liquid protective fluid 100μL / tube 1 tube / box colorless transparent liquid Pre-hybridization solution 1300μL / tube 2 tubes / box colorless transparent liquid Right-sense hybridization solution 10μL / tube 1 tube / box colorless transparent liquid antisense hybridization solution 10μL / tube 1 tube / box colorless transparent liquid blocking solution 1000μL / tube 1 tube / box colorless transparent liquid Alkaline phosphatase antibody 1 μL / tube 1 tube / box colorless transparent liquid ...

Embodiment 2

[0065] The implementation process of applying the nucleic acid in situ hybridization detection method to the beta-catenin gene expression of each group of blood samples:

[0066] 1).Take two specimens to be tested;

[0067] 2). Add 50 ml of digestive solution (100 μL of digestive solution plus 99.9 ml of 1× buffer Ⅰ, which is the concentration used) in a glass tank, preheat in a water bath at 37°C for 10 minutes, put 16 slides in, and treat at 37°C for 12 minutes , and then washed with 1× buffer I for 5 min;

[0068] 3). Wash with 0.2% protection solution (protection solution 1ml plus 1× buffer Ⅰ, 99ml is the used concentration) for 10 minutes, three-distilled water for 5 minutes (the above process is carried out in a glass tank), take out the slide and let it naturally dry;

[0069] 4). Put the slides into a humidifying box, add 25 μL / slice of pre-hybridization solution (add to the place where there are cells), cover with a cover glass, cover the humidifying box tightly, an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an in-situ hybridization detection kit. The in-situ hybridization detection kit comprises a hybridization detection kit probe and a marker. The invention further discloses an mRNA (Messenger Ribonucleic Acid) method of a signal channel (beta-catenin) closely related with pathologic evolution of liver cancer prophase by using in-situ hybridization of the kit. The mRNA method comprises the following steps: firstly, on the condition that the hybridization probe and a target sequence can form a stable hybridization complex, contacting RNA to be detected in a substrate with the hybridization probe to form a hybridization complex; and secondly, detecting the hybridization complex. The kit and the detection method disclosed by the invention can be used for detecting the expression of the beta-catenin gene on the mRNA level; and compared with imaging medicine and a traditional clinical biochemical detection index, the kit and the detection method can be used for really realizing mRNA level screening of canceration prophase at earlier stage. Meanwhile, the detection method disclosed by the invention is simple and convenient and low in cost and is convenient to popularize and apply to county hospitals.

Description

technical field [0001] The present invention relates to the field of biological detection, more specifically, relates to the detection technology related to the change of mRNA expression (pathological evolution process) of precancerous changes. Background technique [0002] According to the information provided by authoritative organizations at home and abroad, there are 2.6 million new cancer cases in my country every year, nearly 2.1 million deaths, and more than 7 million patients. Globally, there are 8 million new cancer patients every year, nearly 8 million deaths, and more than 8,400 patients. Ten thousand people, the number will double by 2020, this is a set of terrible figures. The cost of cancer diagnosis and treatment is getting higher and higher. The annual treatment cost of cancer patients is 200,000 yuan (may be higher in poor areas, and 200,000 yuan in developed areas). For more than 7 million patients, the annual cost is 1.4 trillion yuan. 35% of the cost is a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 张玉丽裘霖张云福裘建英
Owner NATUREGEN BIOTECH SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap